Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 35%
Hold 24%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is positioned to continue its growth trajectory with a solid portfolio of trusted brands and a strong foothold in international markets, accounting for 70% of its total business. While encountering near-term challenges such as cost inflation and slow growth in North America, the company's focus on sustainability and social impact initiatives, cost-saving programs, and potential for market share gains and growth opportunities through new product launches and expansion of existing brands set a positive outlook for long-term growth.

Bears say

Colgate-Palmolive is a well-established player in the household and personal care industry with international sales accounting for 70% of its total business. Despite a strong diversity and inclusion strategy, headwinds such as higher oil-derived input costs and industry challenges related to the conflict in Iran could impact the company's margins and growth. Additionally, the company's slower start in North America and a lower estimated multiple reflect a negative outlook on the stock.

Colgate-Palmolive (CL) has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 35% recommend Buy, 24% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 17 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Jun 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $95.35, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $95.35, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.